Journal article
The feasibility and generalizability of assessing the appropriateness of antimicrobial prescribing in hospitals: a review of the Australian National Antimicrobial Prescribing Survey
R James, Y Nakamachi, A Morris, M So, SSLS Ponnampalavanar, P Chuki, LS Loong, PSM Lai, C Chen, R Ingram, A Rajkhowa, K Buising, K Thursky
Jac Antimicrobial Resistance | OXFORD UNIV PRESS | Published : 2022
Open access
Abstract
The National Antimicrobial Prescribing Survey (NAPS) is a web-based qualitative auditing platform that provides a standardized and validated tool to assist hospitals in assessing the appropriateness of antimicrobial prescribing practices. Since its release in 2013, the NAPS has been adopted by all hospital types within Australia, including public and private facilities, and supports them in meeting the national standards for accreditation. Hospitals can generate real-time reports to assist with local antimicrobial stewardship (AMS) activities and interventions. De-identified aggregate data from the NAPS are also submitted to the Antimicrobial Use and Resistance in Australia surveillance syst..
View full abstractGrants
Awarded by National Centre for Antimicrobial Stewardship, Centre of Research Excellence (National Health and Medical Research Council)
Awarded by BD Canada
Awarded by Pfizer Independent Grants for Learning Change (IGLC)
Funding Acknowledgements
The Australian NAPS programme is supported by the Australian Commission on Safety and Quality in Health Care and the Australian Government's Department of Health, the Guidance Group, Royal Melbourne Hospital and the National Centre for Antimicrobial Stewardship, Centre of Research Excellence (National Health and Medical Research Council grant APP1079625). The Canadian NAPS pilot programme was supported by the Public Health Agency of Canada, an unrestricted grant from BD Canada (AGR2017-04251JH), and in-kind resources from the Sinai Health-University Health Network Antimicrobial Stewardship Program. Pfizer Independent Grants for Learning & Change (IGLC) provided project funding (40867041) and The Joint Commission (USA) provided administrative oversight for the Malaysian NAPS pilot. The NAPS project in Bhutan received funding support from the UK Fleming Fund programme on AMR.